To create a unique version of the provided article for WordPress, the content can be rewritten as follows:
President Trump urged pregnant women to avoid taking Tylenol in a White House announcement in September 2025.
Francis Chung/Politico/Bloomberg via Getty Images
hide caption
toggle caption
Francis Chung/Politico/Bloomberg via Getty Images
President Trump’s statement in September 2025 advising pregnant women to avoid Tylenol due to a potential autism risk had a significant impact, leading to a decrease in emergency room orders for the medication, according to a study published in The Lancet.
Despite medical professionals refuting the claim made by the president, the study revealed a noticeable decline in Tylenol prescriptions for pregnant patients following the announcement.
The study’s lead researcher, Dr. Jeremy Faust from Brigham and Women’s Hospital, noted the immediate impact of the president’s words on medication orders in emergency departments.
Further analysis is needed to understand the full extent of the influence of such public statements on healthcare practices.
The study also highlighted a surge in prescriptions for leucovorin, a B vitamin, following the president’s suggestion as an autism treatment, indicating the significant impact of public figures on healthcare decisions.
While the study raises concerns about the influence of unsubstantiated claims on medical practices, it also emphasizes the importance of evidence-based medicine in guiding patient care.
